Infliximab for hard-to-treat brain blood vessel aneurysms
Treatments studied
Part of Brain & nervous system, Heart & circulation clinical trials.
This Phase 1/2 trial tests infliximab, a medicine that calms inflammation, for dolichoectactic aneurysms in the vertebral/basilar brain blood vessels that usually cannot be treated with standard surgery or procedures. The goal is to see if it can improve safety and how the aneurysm behaves over time.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You’re an adult (18 or older) when you start the study drug.
- Your vertebral and/or basilar artery aneurysm can’t be treated with usual surgery or catheter-based procedures.
- You have not taken infliximab’s type of medicines (anti‑TNF/other biologic drugs) in the last 12 months.
- Your blood and organ tests are in safe ranges (not very low white cells or platelets, not severe anemia, and kidney/liver levels not too high).
- You’re willing to be checked for prior or active tuberculosis (TB) and must have treatment documented if you’ve had TB exposure.
- You can have MRI scans as part of the study and follow all study visits and rules.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This Phase 2 trial tests tocilizumab and tofacitinib to see if they can better control vascular (blood-vessel) Behçet’s syndrome. It may help by lowering inflammation and reducing complications from aneurysms in the aorta or peripheral arteries.
This trial uses a computer model to study how the body processes infliximab (a medicine that reduces inflammation) in people with Crohn's disease or ulcerative colitis. It aims to find the best dose to help control symptoms.
This trial tests a more precise way to start infliximab (a Crohn’s medicine) and adjust dosing based on how your body responds. It aims to better control Crohn’s inflammation early and keep it under control.
This trial is testing a new way to give infliximab, a treatment for moderate to severe Crohn's disease, as a shot under the skin. It's for people who haven't gotten better with other treatments or need strong medication right away.
This trial tests if a medicine called infliximab, given through an IV, can help improve thinking and memory problems in people with moderate to severe depression who also have high inflammation levels. It aims to see if lowering inflammation can ease both mood and cognitive symptoms.
This trial checks if adding an interleukin-6 receptor inhibitor (a drug that reduces inflammation) to standard emergency clot removal can improve recovery for people with a severe stroke affecting the back part of the brain (posterior circulation). It is for patients who need urgent treatment within 24 hours of symptom onset.
Hear when a new Aneurysm trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.